Eli Lilly just crushed earnings again and sits within striking distance of its all-time high, but a looming price war with Novo Nordisk and a dangerously concentrated revenue base raise real questions about how…
Morgan Stanley just put a bold new target on Amazon and called it a top pick, but the reasons behind the upgrade go far beyond the cloud spending story investors already know.
EQT just raised its dividend again, but with buybacks taking priority and natural gas prices still volatile, income investors need to know exactly how much pressure the payout can withstand before the raises stop…
Early Solana and Ethereum investors turned small bets into life-changing fortunes, but both coins now sit far below their peaks with ETF outflows mounting. The path to another millionaire-making run by 2030 requires clearing…
Jensen Huang says compute is now revenue, and NVIDIA's latest numbers back him up. But whether Wall Street's already-aggressive targets actually undershoot where this stock is headed depends on a few catalysts that could…
A trader on Reddit’s r/wallstreetbets says he turned an Advanced Micro Devices (NASDAQ:AMD | AMD Price Prediction) position into a fortune, then sold all of it. On October 16, 2026, user DubiousChemistry posted “+$16,000,000…
A new federal cloud alliance is putting Palantir Technologies (NASDAQ:PLTR | PLTR Price Prediction) well ahead of the government contractors it competes with for agency software work. Palantir stock is up 5% to $195.36…
Antimony is trading on its own story as the critical minerals complex splits in two. United States Antimony (NYSEAMERICAN:UAMY) shares are up 11% to $3.18, breaking clearly from the rare earth names around it.…
Although Wall Street spent much of October worrying about a tech slump, Apple (NASDAQ:AAPL | AAPL Price Prediction) stock pushed to new highs as its first foldable phone arrived. Apple opened worldwide preorders for…
Both payroll giants just handed investors a 10% dividend raise, yet one pays nearly twice the yield of the other while trading at a steeper discount. The right pick depends on a tension between…
The AI boom has pushed American stocks to valuations few living investors have seen. Meanwhile, one of Wall Street’s most respected financial historians argues that the money pouring in is itself the warning sign.…
One crypto tripled on a landmark bank network deal while the other quietly bleeds alongside the broader altcoin market. Before you chase the winner or bet on a rebound, there are red flags in…
Palantir just posted its fastest commercial growth ever, but the valuation math raises a question that every investor needs to answer before buying in at current prices.
Pfizer's 5.8% yield looks tempting until you check what the dividend is actually costing the company relative to its cash generation. The math behind that payout is more uncomfortable than the headline numbers suggest.
Bitcoin's price swings have compressed to their tightest range in 2.5 years, a pattern that historically signals a violent move is near. But traders who called the last squeeze bullish got burned first, and…
